| |
Number of patients |
| Patients on prednisone at start of trial |
14 |
| Patients able to reduce prednisone dosage to zero |
9 out of 14 (64%) |
| Patients with reduced visual acuity at start of trial |
12 (86%) |
| Patients able to improve acuity by at least two lines |
7 out of 12 (58%) |
| Patients with abnormal exophthalmometry |
10 (71%) |
| Patients with improved exophthalmometry at the end of trial |
3 out of 10 (30%) |
| Patients with EOMs restriction |
13 (93%) |
| Patients with improved EOMs at the end of trial |
5 out of 13 (38%) |
